ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Specialist

Top Specialist Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FADI ABOU-ISSA MD

Specialist

39,657

$2.45M

1059
760 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

29%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $81

OSCAR RODRIGUEZ M.D.

Specialist

24,064

$1.48M

455
314 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

31%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $81

EDUARDO ALVAREZ M.D.

Specialist

23,871

$1.65M

437
314 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

32%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $81

CARLOS RODRIGUEZ FIERRO M.D.

Specialist

19,070

$1.27M

1422
1182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

29%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $81

SAMER ROY MD

Specialist

16,432

$923K

537
417 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

29%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $81

BRUCE ITELD MD,FACC,FCCP,FSCAI

Specialist

15,082

$1.05M

875
716 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

31%
prescriptions for brand name drugs

Avg: 28%

$70
Average prescription price

Avg: $81

JAMES ROONEY M.D.

Specialist

14,998

$978K

797
684 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

26%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $81

RAYNANDO BANKS M.D.

Specialist

12,866

$617K

418
234 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

22%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $81

YU-CHENG JEFFREY CHEN M.D.

Specialist

12,664

$710K

814
677 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

27%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $81

STEPHEN KATZ M.D.

Specialist

12,645

$827K

777
301 are 65+

62%
patients receiving schedule two controlled substances

Avg: 5%

36%
patients receiving schedule three controlled substances

Avg: 16%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

23%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $81

ALPESH PATEL MD

Specialist

11,911

$793K

888
315 are 65+

68%
patients receiving schedule two controlled substances

Avg: 5%

43%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

14%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $81

MARIO MORENO M.D.

Specialist

10,964

$442K

490
395 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

17%
prescriptions for brand name drugs

Avg: 28%

$40
Average prescription price

Avg: $81

MICHAEL GUARISCO M.D.

Specialist

10,646

$541K

644
481 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

21%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $81

LEONARD COLLIER M.D.

Specialist

10,581

$550K

300
207 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

40%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

27%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $81

RAJAT BHUSHAN

Specialist

9,644

$1.33M

788
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

55%
prescriptions for brand name drugs

Avg: 28%

$138
Average prescription price

Avg: $81

SERGIO BARRIOS M.D.

Specialist

9,362

$469K

755
635 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

23%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $81

STEPHEN SALOPEK, JR. M.D.

Specialist

9,032

$576K

387
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

31%
prescriptions for brand name drugs

Avg: 28%

$64
Average prescription price

Avg: $81

EDWARD HAIGHT M.D.

Specialist

8,731

$1.15M

706
490 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

30%
prescriptions for brand name drugs

Avg: 28%

$132
Average prescription price

Avg: $81

ROBERT SONGY M.D.

Specialist

8,429

$578K

428
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

37%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $81

WAYNE PHARO M.D.

Specialist

8,406

$516K

510
434 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

29%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $81

VADAKKIPALAYAM DEVARAJAN

Specialist

8,167

$564K

452
339 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

21%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $81

CHEMMALE JAYAKRISHNAN

Specialist

8,069

$347K

449
354 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

19%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $81

RODOLFO MANALAC MD

Specialist

8,015

$406K

307
234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

26%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $81

RAFAEL ROBLEDO M.D.

Specialist

7,861

$487K

543
341 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

28%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $81

ANTHONY MORALES M.D.

Specialist

7,757

$418K

781
674 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

22%
prescriptions for brand name drugs

Avg: 28%

$54
Average prescription price

Avg: $81

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank